Clinical Trials Logo

Fibromyalgia (FM) clinical trials

View clinical trials related to Fibromyalgia (FM).

Filter by:
  • None
  • Page 1

NCT ID: NCT05230602 Active, not recruiting - Fibromyalgia (FM) Clinical Trials

Consuming of Opuntia Among Women With Fibromyalgia

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

To examine whether the addition of tzabar fruit twice a day to a routine daily nutrition regime will: A- Reduce symptoms of fatigue, pain and depression in FM patients B. Have positive influence on quality of life

NCT ID: NCT04174300 Completed - Clinical trials for Chronic Fatigue Syndrome (CFS)

Molecular Response to Custom Manual Physiotherapy Treatment of Fibromyalgia & Chronic Fatigue Syndrome (CFS)

Start date: March 20, 2019
Phase: N/A
Study type: Interventional

Fibromyalgia (FM)and Chronic Fatigue Syndrome (CFS) are complex diseases often presenting overlapping symptomatology. Manual therapy (MT) protocols report benefits for pain treatment of FM, but the underlying mechanisms for patient improvement remain unknown. The main goal of this study is to assess the molecular changes associating to mechanical and additional MT triggers, possibly involved in patient symptom improvement.

NCT ID: NCT02146495 Completed - Fibromyalgia (FM) Clinical Trials

Targeted Limbic Self-modulation as a Potential Treatment for Patients Suffering From Fibromyalgia

Start date: January 2017
Phase: N/A
Study type: Interventional

The goal of this study is to test whether voluntary regulation of limbic system activation is possible in patients with fibromyalgia and to examine the neurobehavioral effects of specific neuromodulation of this circuit on somatosensory, limbic, and cognitive processes. This goal will be achieved by using a method previously developed for the construction of an fMRI-enriched EEG model ("EEG-Finger-Print", EFP) that selectively targets the amygdala BOLD activation (Amyg-EFP). The investigators conducted two studies: In the first study, the investigators conducted simultaneous recordings of EEG and fMRI during Amyg-EFP NF training on patients with FM. The main objective is to demonstrate target engagement following Amyg-EFP-NF training in FM patients. In the second study, the investigators aim to conduct a randomized clinical trial to examine the causal effect of the Amyg-EFP NF trial. The investigators will compare neurobehavioral effects between three groups. I. Amyg-EFP-NF group: a multisession NF trial using the Amyg-EFP model. II. Control group 1- sham-NF: a multisession NF trial using sham feedback. III. Control group 2: patients in this group will continue their usual treatment without intervention.